Sign in

CIK 0000014272

  • Large accelerated filer

BRISTOL MYERS SQUIBB CO

Sign in to watch
Ticker
BMY
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
220790350
Phone
+1 609-252-4621
Business address
ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543

Securities

  • BMY Bristol-Myers Squibb Company Common Stock NYSE
  • CELG-RI Rights NYSE
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$677,826
in 3 filings

Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-03-10 Santiago Karen Murphy SVP & Controller Shares withheld for taxes −468 $68.42 $32K 16,731
2022-03-10 Santiago Karen Murphy SVP & Controller Option exercise +1,154 17,885
2022-03-10 Santiago Karen Murphy SVP & Controller Other acquisition +129 18,014
2022-03-10 Santiago Karen Murphy SVP & Controller Shares withheld for taxes −464 $68.42 $32K 17,550
2022-03-10 Santiago Karen Murphy SVP & Controller Option exercise +6,939 24,489
2022-03-10 Santiago Karen Murphy SVP & Controller Other acquisition +3,292 27,781
2022-03-10 Santiago Karen Murphy SVP & Controller Shares withheld for taxes −4,500 $68.42 $308K 23,281
2022-03-10 Santiago Karen Murphy SVP & Controller Option exercise · Market Share Units −683 0
2022-03-10 Santiago Karen Murphy SVP & Controller Option exercise · Market Share Units −1,156 1,158
2022-03-10 Santiago Karen Murphy SVP & Controller Option exercise · Market Share Units −1,141 2,282
2022-03-10 Santiago Karen Murphy SVP & Controller Option exercise · Market Share Units −1,154 3,465
2022-03-10 Santiago Karen Murphy SVP & Controller Grant or award · Market Share Units +3,245 3,245
2022-03-10 Santiago Karen Murphy SVP & Controller Option exercise · Performance Shares −6,939 0
2022-03-10 Santiago Karen Murphy SVP & Controller Grant or award · Performance Shares +4,868 4,868
2022-03-10 VESSEY RUPERT EVP, Research & Early Dev. Option exercise +7,423 76,707
2022-03-10 VESSEY RUPERT EVP, Research & Early Dev. Other acquisition +981 77,688
2022-03-10 VESSEY RUPERT EVP, Research & Early Dev. Shares withheld for taxes −4,299 $68.42 $294K 73,389
2022-03-10 VESSEY RUPERT EVP, Research & Early Dev. Option exercise +7,824 81,213
2022-03-10 VESSEY RUPERT EVP, Research & Early Dev. Other acquisition +878 82,091
2022-03-10 VESSEY RUPERT EVP, Research & Early Dev. Shares withheld for taxes −4,452 $68.42 $305K 77,639

Page 64 of 73 · 1,445 trades